Your browser doesn't support javascript.
loading
High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer.
Wang, Guoliang; Huang, Yi; Yang, Feilong; Tian, Xiaojun; Wang, Kun; Liu, Li; Fan, Yidong; Li, Xiaofeng; Li, Luchao; Shi, Benkang; Hao, Yichang; Xia, Chuanyou; Nie, Qingsheng; Xin, Yue; Shi, Zhenfeng; Ma, Lulin; Xu, Dawei; Liu, Cheng.
Afiliación
  • Wang G; Department of Urology, Peking University Third Hospital, Beijing, China.
  • Huang Y; Department of Urology, Peking University Third Hospital, Beijing, China.
  • Yang F; Department of Urology, Peking University Third Hospital, Beijing, China.
  • Tian X; Department of Urology, Peking University Third Hospital, Beijing, China.
  • Wang K; Department of Urology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre for Cancer, Key Lab for Cancer Prevention and Therapy, Tianjin, China.
  • Liu L; School of Nursing, Beijing University of Chinese Medicine, Beijing, China.
  • Fan Y; Department of Urology, Shandong University Qilu Hospital, Jinan, China.
  • Li X; Department of Urology, Shandong University Qilu Hospital, Jinan, China.
  • Li L; Department of Urology, Shandong University Qilu Hospital, Jinan, China.
  • Shi B; Department of Urology, Shandong University Qilu Hospital, Jinan, China.
  • Hao Y; Department of Urology, Peking University Third Hospital, Beijing, China.
  • Xia C; Department of Medicine, Bioclinicum and Centre for Molecular Medicine, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.
  • Nie Q; Department of Urology, The Central Hospital of Zibo, Zibo, China.
  • Xin Y; Department of Urology, Chifeng University Second Hospital, Chifeng, China.
  • Shi Z; Department of Urology, The People's Hospital of Xinjiang Uyghur Autonomous Region, Xinjiang, China.
  • Ma L; Department of Urology, Peking University Third Hospital, Beijing, China.
  • Xu D; Department of Medicine, Bioclinicum and Centre for Molecular Medicine, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.
  • Liu C; Karolinska Institute-Shandong University Collaborative Laboratory for Cancer and Stem Cell Research, Jinan, China.
Aging (Albany NY) ; 12(3): 2030-2048, 2020 02 01.
Article en En | MEDLINE | ID: mdl-32007952
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / N-Metiltransferasa de Histona-Lisina / Receptor IGF Tipo 1 / Proteínas Proto-Oncogénicas c-akt / Factor de Transcripción E2F1 Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Aging (Albany NY) Asunto de la revista: GERIATRIA Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / N-Metiltransferasa de Histona-Lisina / Receptor IGF Tipo 1 / Proteínas Proto-Oncogénicas c-akt / Factor de Transcripción E2F1 Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Aging (Albany NY) Asunto de la revista: GERIATRIA Año: 2020 Tipo del documento: Article País de afiliación: China